Latest Headlines

  1. GSK Announces Drug Manufacturing Expansion In Pennsylvania 10/13/2026

    Today, Governor Josh Shapiro and Department of Community and Economic Development (DCED) Secretary Rick Siger announced the Commonwealth has secured an over $800 million investment from global biopharma company GSK to expand its operations in Montgomery County. The expansion will create more than 300 new jobs over the next five years, retain approximately 4,500 existing full-time jobs across the Commonwealth, and continue growing Pennsylvania’s robust life sciences industry.

  2. Contec Launches Sterile ReadySAT™ With PeridoxRTU® Sporicidal Wipes For Cleanrooms 10/7/2026

    Contec, Inc. announces the launch of sterile ReadySAT™ with PeridoxRTU® Sporicidal Wipes. Validated sterile and suitable for ISO 3-8 cleanrooms, the wipes support surface disinfection in the most critical cleanroom environments.

  3. Upperton Unveils New Brand Identity Reflecting Evolution Into Specialist CDMO 10/6/2026

    Upperton has unveiled a new brand identity at CPHI Milan, marking a significant milestone in the company's evolution into a specialist, end-to-end contract development and manufacturing organisation (CDMO) focused on solving the challenges of molecule development across oral, nasal, pulmonary and parenteral dosage forms.

  4. Hovione To Commission World's First ConsiGma® CDC Flex, Bringing Next-Generation Continuous Tableting To The U.S. 10/5/2026

    Hovione, a globally integrated pharmaceutical contract development and manufacturing organization (CDMO), today announced it will commission the world’s first ConsiGma® CDC Flex – a next generation continuous tableting line – at its East Windsor, New Jersey campus in late 2027. The line will be installed at 89 Twin Rivers, Hovione's recently opened facility, expanding the company´s drug product capabilities and strengthening its integrated pharmaceutical development and manufacturing hub in the U.S.

  5. Agilent Expands Oligonucleotide Manufacturing Capabilities With New Boulder Lab 10/5/2026

    Agilent Technologies Inc. (NYSE: A) today announced the addition of new laboratory space in Boulder, Colorado, to support the expansion of its oligonucleotide manufacturing capabilities. The facility is expected to support the development and scale-up of emerging manufacturing technologies for oligonucleotide therapeutics, initially focusing on enzymatic ligation.

  6. Flamma Acquires API Manufacturing Site In Padova, Italy 10/5/2026
  7. Bayer Expanding U.S. Pharmaceutical Manufacturing Footprint With New Ohio Manufacturing Facility 10/5/2026

    Company plans to build state-of-the-art site in New Albany, Ohio, U.S., to serve patients in the U.S. as well as globally / Bayer expects to create around 600 new high-value jobs in the area / Multi-year investment reinforces U.S. business expansion and adds to more than seven billion dollars in U.S. pharma R&D and manufacturing expenditure over past five years.

  8. ROSS 600-Gallon ASME Pressure Vessel For High-Pressure Processing 10/1/2026

    ROSS’s Tank and Fabrication Division is a full service manufacturer of custom pressure vessels, storage tanks and reactors for virtually any application. One example is the pictured pressure vessel with a 600-gallon full holding capacity and rated for 300 psi at 200 F.

  9. METTLER TOLEDO Expands Foreign Material Re-Inspection Services With New Dallas Facility 9/30/2026

    METTLER TOLEDO announced today that its new X-ray Reclaim Foreign Material Re-inspection Services facility in Dallas, Texas, is scheduled to open on October 5, 2026.

  10. Serán Bioscience Strengthens Spray Dry Capabilities With Growth Investment From Biospring Partners To Accelerate Commercial Expansion And Meet Surging Customer Demand 9/30/2026

    Serán Bioscience (“Serán” or “the Company”), a leading contract development and manufacturing organization (CDMO) specializing in development, analytical and manufacturing solutions to pharmaceutical and biotechnology companies, today announced a growth investment led by Biospring Partners with continued participation from existing investors Vivo Capital, Bain Capital Life Sciences (“Bain Capital”), as well as Serán’s executive leadership.